Narrative Update • Jul 22
Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Biotech Industry Analysis
UpdatedJul 30, 2026
DataAggregated Company Financials
Companies35
- 7D-3.8%
- 3M-25.5%
- 1Y-34.9%
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 3.8%, driven by GNI Group declining 9.8%. Meanwhile, Innovacell actually outperformed within the industry, gaining 17% in the last week. The industry has fallen 35% in the last year. As for the next few years, earnings are expected to grow by 34% per annum.
Industry Valuation and Performance
Has the Japanese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 30 Jul 2026 | JP¥782.8b | JP¥159.3b | -JP¥44,571,531,682.00 | 29.1x | -17.6x | 4.9x |
| Sat, 27 Jun 2026 | JP¥774.0b | JP¥159.3b | -JP¥42,113,283,682.00 | 27.9x | -18.4x | 4.9x |
| Mon, 25 May 2026 | JP¥1.1t | JP¥198.8b | -JP¥57,268,334,682.00 | 47.2x | -19x | 5.5x |
| Wed, 22 Apr 2026 | JP¥1.2t | JP¥202.7b | -JP¥49,271,096,682.00 | 65.1x | -24.5x | 6x |
| Fri, 20 Mar 2026 | JP¥1.1t | JP¥202.7b | -JP¥49,460,978,682.00 | 58x | -22.7x | 5.5x |
| Sun, 15 Feb 2026 | JP¥1.1t | JP¥200.0b | -JP¥53,960,391,000.00 | 307.9x | -20.8x | 5.6x |
| Tue, 13 Jan 2026 | JP¥1.0t | JP¥198.7b | -JP¥70,727,387,000.00 | 56.4x | -14.8x | 5.3x |
| Thu, 11 Dec 2025 | JP¥1.0t | JP¥196.3b | -JP¥69,395,659,000.00 | 48.4x | -14.6x | 5.2x |
| Sat, 08 Nov 2025 | JP¥1.1t | JP¥197.5b | -JP¥65,616,231,000.00 | 62.8x | -16.4x | 5.4x |
| Mon, 06 Oct 2025 | JP¥1.1t | JP¥197.7b | -JP¥65,794,561,000.00 | 63.9x | -17.4x | 5.8x |
| Wed, 03 Sep 2025 | JP¥1.2t | JP¥193.5b | -JP¥68,135,862,000.00 | 121.8x | -17.4x | 6.1x |
| Fri, 01 Aug 2025 | JP¥1.2t | JP¥218.1b | -JP¥46,562,710,000.00 | 107.9x | -25x | 5.3x |
| Sun, 29 Jun 2025 | JP¥1.1t | JP¥218.2b | -JP¥43,672,020,000.00 | 94.5x | -25x | 5x |
| Tue, 27 May 2025 | JP¥1.2t | JP¥214.8b | -JP¥40,595,527,000.00 | 15x | -28.5x | 5.4x |
| Thu, 24 Apr 2025 | JP¥1.0t | JP¥207.8b | -JP¥39,029,205,000.00 | 14.3x | -26.5x | 5x |
| Sat, 22 Mar 2025 | JP¥1.0t | JP¥207.8b | -JP¥39,285,917,000.00 | 15.9x | -26.7x | 5x |
| Mon, 17 Feb 2025 | JP¥1.1t | JP¥207.4b | -JP¥38,725,311,000.00 | 16.1x | -27.6x | 5.2x |
| Wed, 15 Jan 2025 | JP¥1.0t | JP¥207.3b | -JP¥13,531,081,000.00 | 21.2x | -75.8x | 4.9x |
| Fri, 13 Dec 2024 | JP¥1.0t | JP¥207.2b | -JP¥12,080,899,000.00 | 21.7x | -86.5x | 5x |
| Sun, 10 Nov 2024 | JP¥1.1t | JP¥215.8b | -JP¥6,555,528,000.00 | 22.3x | -164.2x | 5x |
| Tue, 08 Oct 2024 | JP¥1.1t | JP¥214.3b | -JP¥2,078,229,000.00 | 21.9x | -550.3x | 5.3x |
| Thu, 05 Sep 2024 | JP¥1.1t | JP¥210.1b | -JP¥469,229,000.00 | 15.6x | -2253.9x | 5x |
| Sat, 03 Aug 2024 | JP¥998.4b | JP¥187.5b | -JP¥16,095,901,000.00 | 54.4x | -62x | 5.3x |
| Mon, 01 Jul 2024 | JP¥994.5b | JP¥187.7b | -JP¥15,773,284,000.00 | 89.8x | -63x | 5.3x |
| Wed, 29 May 2024 | JP¥786.6b | JP¥195.7b | -JP¥14,072,545,000.00 | 94.6x | -55.9x | 4x |
| Fri, 26 Apr 2024 | JP¥745.6b | JP¥198.9b | -JP¥14,917,877,000.00 | 41.6x | -50x | 3.7x |
| Sun, 24 Mar 2024 | JP¥773.8b | JP¥194.2b | -JP¥15,457,633,000.00 | 60.7x | -50.1x | 4x |
| Tue, 20 Feb 2024 | JP¥834.1b | JP¥196.2b | -JP¥18,777,765,000.00 | 66.2x | -44.4x | 4.3x |
| Thu, 18 Jan 2024 | JP¥782.4b | JP¥222.3b | -JP¥12,605,455,000.00 | 17.2x | -62.1x | 3.5x |
| Sat, 16 Dec 2023 | JP¥751.0b | JP¥221.9b | -JP¥12,379,781,000.00 | 16.9x | -60.7x | 3.4x |
| Mon, 13 Nov 2023 | JP¥735.1b | JP¥221.2b | -JP¥8,793,085,000.00 | 17.1x | -83.6x | 3.3x |
| Wed, 11 Oct 2023 | JP¥824.5b | JP¥223.0b | -JP¥14,518,735,000.00 | 24.3x | -56.8x | 3.7x |
| Fri, 08 Sep 2023 | JP¥894.4b | JP¥225.4b | -JP¥19,581,085,000.00 | 45.4x | -45.7x | 4x |
| Sun, 06 Aug 2023 | JP¥894.4b | JP¥223.7b | -JP¥20,858,086,000.00 | 49.8x | -42.9x | 4x |
Price to Earnings Ratio
-42.9x
Current Industry PE
- Investors are relatively neutral on the Japanese Biotechnology industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 4.9x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 11% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Japanese Biotech compare with similar industries?
| JP Market | -2.05% | |
| Healthcare | 2.33% | |
| Biotech | -3.77% | |
| Biotech | -3.77% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 504A Innovacell | JP¥510.00 | 14.9% +JP¥3.0b | n/a | PB2.3x | |
| 7774 Japan Tissue Engineering | JP¥660.00 | 4.3% +JP¥1.1b | 13.4% | PS12.3x |